BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chatziharalambous D, Lygirou V, Latosinska A, Stravodimos K, Vlahou A, Jankowski V, Zoidakis J. Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation. PLoS One 2016;11:e0149471. [PMID: 26889680 DOI: 10.1371/journal.pone.0149471] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Kontostathi G, Makridakis M, Bitsika V, Tsolakos N, Vlahou A, Zoidakis J. Development and Validation of Multiple Reaction Monitoring (MRM) Assays for Clinical Applications. In: Brun V, Couté Y, editors. Proteomics for Biomarker Discovery. New York: Springer; 2019. pp. 205-23. [DOI: 10.1007/978-1-4939-9164-8_14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gubala V, Giovannini G, Kunc F, Monopoli MP, Moore CJ. Dye-doped silica nanoparticles: synthesis, surface chemistry and bioapplications. Cancer Nano 2020;11. [DOI: 10.1186/s12645-019-0056-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
3 Coto L, Mendia I, Sousa C, Bai JC, Cebolla A. Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review. World J Gastroenterol 2021; 27(37): 6306-6321 [PMID: 34712034 DOI: 10.3748/wjg.v27.i37.6306] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gleichenhagen J, Arndt C, Casjens S, Meinig C, Gerullis H, Raiko I, Brüning T, Ecke T, Johnen G. Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine. Int J Mol Sci 2018;19:E226. [PMID: 29324722 DOI: 10.3390/ijms19010226] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
5 Harpole M, Davis J, Espina V. Current state of the art for enhancing urine biomarker discovery. Expert Rev Proteomics 2016;13:609-26. [PMID: 27232439 DOI: 10.1080/14789450.2016.1190651] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 9.6] [Reference Citation Analysis]
6 Humayun-Zakaria N, Ward DG, Arnold R, Bryan RT. Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein? Transl Androl Urol 2021;10:2787-808. [PMID: 34295762 DOI: 10.21037/tau-20-1327] [Reference Citation Analysis]
7 Chauhan VM, Elsutohy MM, McClure CP, Irving WL, Roddis N, Aylott JW. Gold-Oligonucleotide Nanoconstructs Engineered to Detect Conserved Enteroviral Nucleic Acid Sequences. Biosensors (Basel) 2021;11:238. [PMID: 34356709 DOI: 10.3390/bios11070238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H. Clinical Proteomics for Precision Medicine: The Bladder Cancer Case. Prot Clin Appl 2018;12:1700074. [DOI: 10.1002/prca.201700074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
9 Allione A, Pardini B, Viberti C, Giribaldi G, Turini S, Di Gaetano C, Guarrera S, Cordero F, Oderda M, Allasia M, Gontero P, Sacerdote C, Vineis P, Matullo G. MMP23B expression and protein levels in blood and urine are associated with bladder cancer. Carcinogenesis 2018;39:1254-63. [PMID: 30052775 DOI: 10.1093/carcin/bgy098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mello LD. Potential contribution of ELISA and LFI assays to assessment of the oxidative stress condition based on 8-oxodG biomarker. Anal Biochem 2021;628:114215. [PMID: 33957135 DOI: 10.1016/j.ab.2021.114215] [Reference Citation Analysis]
11 Saengdee P, Thanapitak S, Ongwattanakul S, Srisuwan A, Pankiew A, Thornyanadacha N, Chaisriratanakul W, Jeamsaksiri W, Promptmas C. A silicon nitride ion sensitive field effect transistor‐based immunosensor for determination of urinary albumin. Electrochemical Science Advances. [DOI: 10.1002/elsa.202100078] [Reference Citation Analysis]
12 Koh JH, Lee S, Kim HS, Lee K, Lee CS, Yoo SA, Lee N, Kim WU. Development of Monitoring System for Assessing Rheumatoid Arthritis within 5 Minutes Using a Drop of Bio-Fluids. J Clin Med 2020;9:E3499. [PMID: 33138147 DOI: 10.3390/jcm9113499] [Reference Citation Analysis]
13 Park J, Lin HY, Assaker JP, Jeong S, Huang CH, Kurdi T, Lee K, Fraser K, Min C, Eskandari S, Routray S, Tannous B, Abdi R, Riella L, Chandraker A, Castro CM, Weissleder R, Lee H, Azzi JR. Integrated Kidney Exosome Analysis for the Detection of Kidney Transplant Rejection. ACS Nano. 2017;11:11041-11046. [PMID: 29053921 DOI: 10.1021/acsnano.7b05083] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
14 Wongta A, Hongsibsong S, Chantara S, Pattarawarapan M, Sapbamrer R, Sringarm K, Xu ZL, Wang H. Development of an Immunoassay for the Detection of Amyloid Beta 1-42 and Its Application in Urine Samples. J Immunol Res 2020;2020:8821181. [PMID: 33426095 DOI: 10.1155/2020/8821181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Szarvas T, Nyirády P, Ogawa O, Furuya H, Rosser CJ, Kobayashi T. Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma. Methods Mol Biol 2018;1655:251-73. [PMID: 28889391 DOI: 10.1007/978-1-4939-7234-0_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Yang Y, Xu J, Zhang Q. Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B. Oncol Lett 2018;15:7923-33. [PMID: 29725479 DOI: 10.3892/ol.2018.8317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
17 Stravinskiene D, Imbrasaite A, Petrikaite V, Matulis D, Matuliene J, Zvirbliene A. New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples. Biomolecules 2019;9:E304. [PMID: 31349673 DOI: 10.3390/biom9080304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Critselis E, Rava M, Marquez M, Lygirou V, Chatzicharalambous D, Liapi P, Lichtinghagen R, Brand K, Cecchini L, Vlahou A, Malats N, Zoidakis J. Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer. Prot Clin Appl 2019;13:1800148. [DOI: 10.1002/prca.201800148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mohan S, Patel S, Greenstein I, Ng C, Frazier K, Nguyen G, Harding L, Barlow D. Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells. Amino Acids 2018;50:1629-36. [PMID: 29922922 DOI: 10.1007/s00726-018-2603-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]